Loading organizations...
Loading organizations...
Innovative biopharmaceutical company developing first-in-class oncology dru
Vidac Pharma has raised $9.0M across 1 funding round.
Vidac Pharma has raised $9.0M in total across 1 funding round.
Vidac Pharma has raised $9.0M in total across 1 funding round.
Vidac Pharma's investors include Ed Saltzman, Mivtach Shamir.
Vidac Pharma has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Series A in June 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 29, 2016 | $9.0M Series A | Ed Saltzman | Mivtach Shamir |